| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.42 | 3e-09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0008 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.002 |